Acarix Q1 2025: Inital take – Softer revenue growth but lower costs than estimated - Redeye
Bildkälla: Stockfoto

Acarix Q1 2025: Inital take – Softer revenue growth but lower costs than estimated - Redeye

Redeye provides its initial take on Acarix’s Q1 report, which showed growth in both revenue and installed systems—though at a slower pace than anticipated. As a result, we expect making downward revisions to our forecasts and fair value range.

Redeye provides its initial take on Acarix’s Q1 report, which showed growth in both revenue and installed systems—though at a slower pace than anticipated. As a result, we expect making downward revisions to our forecasts and fair value range.
Börsvärldens nyhetsbrev